Horizon Pharma Inc. (HZNP) reported that its fourth-quarter net loss was $24.3 million, or $0.40 per share, compared to a net loss of $76.7 million, or $3.92 per share in the same quarter last year.
Non-GAAP net loss for the quarter was $20.9 million, or $0.34 per share, compared to a non-GAAP net loss of $19.0 million, or $0.97 per share, in the fourth quarter of 2011.
Net sales for the quarter were $6.7 million, up from $3.5 million in the fourth quarter of 2011.
Analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $7.59 million for the quarter. Analysts' estimates typically exclude special items.
For comments and feedback: editorial@rttnews.com